Updated recommendations for the management of upper respiratory tract infections in South Africa

South African Medical Journal

Volumn 105, Issue 5, 2015, Pages 345-352

  Brink, A J ^a   Cotton, M F ^b   Feldman, C ^c   Finlayson, H ^b   Friedman, R L ^d   Green, R ^e   Hendson, W ^f   Hockman, M H ^d   Maartens, G ^g   Madhi, S A ^h   Reubenson, G ^f   Silverbauer, E J ⁱ   Zietsman, I L ^i,j  

^a MILPARK HOSPITAL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d Netcare   (South Africa)

^e UNIVERSITY OF PRETORIA   (South Africa)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ Ampath Trust   (South Africa)

^j Working Group of the Infectious Diseases Society   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BENZATHINE PENICILLIN; BETA LACTAMASE; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN ESTOLATE; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN DERIVATIVE; TELITHROMYCIN; ANTIINFECTIVE AGENT;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL SINUSITIS; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; HAEMOPHILUS INFLUENZAE; HUMAN; META ANALYSIS (TOPIC); NONHUMAN; PENICILLIN RESISTANCE; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOUTH AFRICA; TONSILLOPHARYNGITIS; TREATMENT DURATION; TYMPANOSTOMY TUBE; UPPER RESPIRATORY TRACT INFECTION; MORBIDITY; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; HUMANS; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY TRACT INFECTIONS; SOUTH AFRICA;

EID: 84930006435     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.8716     Document Type: Article

References (31)

1. Brink AJ, Cotton MF, Feldman C, et al. for the Working Group of the Infectious Diseases Society of South Africa. Guideline for the management of upper respiratory tract infections. S Afr Med J 2004;94(6):475-483.
2. Brink AJ, Cotton MF, Feldman C, et al. for the Working Group of the Infectious Diseases Society of Southern Africa. Updated guideline for the management of upper respiratory tract infections in South Africa: 2008. S Afr J Epidemiol Infect 2008;23(4):27-40.
3. Jacobs MR. World trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J 2003;22(8):S109-S119. [http://dx.doi.org/10.1097/00006454-200303000-00005].
4. Hockman MH. The effect of Prevnar vaccination on otitis media in Gauteng, South Africa. Presented at the 11th European Symposium on Paediatric Cochlear Implantation (ESPCI), Istanbul, Turkey, 18-21 May 2013.
5. Chow AW, Benninger MS, Brook I, et al. IDSA Clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012;54(8):1041-1045. [http://dx.doi.org/10.1093/cid/cir1043].
6. Van Driel ML, De Sutter AIM, Keber N, Habraken H, Christiaens T. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev 2013, Issue 4. Art. No.: CD004406. [http://dx.doi.org/10.1002/14651858.CD004406.pub3].
7. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013;131(3):e964-e999. [http://dx.doi.org/10.1542/peds.2012-3488].
8. Pechere JC. Parameters important in short antibiotic courses. J Int Med Res 2000;28(Suppl 1):3A-12A.
9. Huebner RE, Wasas AD, Hockman M, Klugman KP, for the ENT Study Group. Bacterial aetiology of non-resolving otitis media in South African children. J Laryngol Otol 2003;117(3):169-172. [http://dx.doi.org/10.1258/002221503321192430].
10. Zietsman IL, Brink AJ. National surveillance of private sector respiratory tract pathogens in South Africa, 2010. S Afr J Epidemiol Infect 2011;26(2):51-53.
11. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis 2012;55(10):1-17 [http://dx.doi.org/10.1093/cid/cis629].
12. Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr 1992;121(4):569-572. [http://dx.doi.org/10.1016/S0022-3476(05)81146-1].
13. Bass JW. A review of the rationale and advantages of various mixtures of benzathine penicillin G. Pediatrics 1996;97(6):960-963.
14. Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J 1998;17(10):890-893. [http://dx.doi.org/10.1097/00006454-199810000-00008].
15. Dicuonzo G, Fiscarelli E, Gherardi G, et al. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 2002;46(12):3987-3990. [http://dx.doi.org/10.1128/AAC.46.12.3987-3990.2002].
16. Reinert RR, Lutticken R, Bryskier A, Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 2003;47(2):489-493. [http://dx.doi.org/10.1128/AAC.47.2.489-493.2003].
17. Clegg HW, Ryan AG, Dallas SD, et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin. Pediatr Infect Dis J 2006;25(9):761-767. [http://dx.doi.org/10.1097/01.inf.0000235678.46805.92].
18. Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis. Arch Dis Child 2008;93(6):474-478. [http://dx.doi.org/10.1136/adc.2006.113506].
19. Dohar J, Giles W, Roland P, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/ clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2006;118(3):e561-e569. [http://dx.doi.org/10.1542/peds.2005-2033].
20. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15(3):255-259. [http://dx.doi.org/10.1097/00006454-199603000-00015].
21. Nicolau DP, Sutherland CA, Arguedas A, Dagan R, Pichichero ME. Pharmacokinetics of cefprozil in plasma and middle ear fluid in children undergoing treatment for acute otitis media. Pediatr Drugs 2007;9(2):119-123. [http://dx.doi.org/10.2165/00148581-200709020-00005].
22. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J 1998;17(12):1126-1131. [http://dx.doi.org/10.1097/00006454-199812000-00005].
23. McGee L, Klugman KP, Wasas A, Capper T, Brink AJ and the Antibiotics Surveillance Forum of South Africa. Serotype 19F multiresistant pneumococcal clone harboring two erythromycin resistance determinants [erm(B) and mef(A)] in South Africa. Antimicrob Agents Chemother 2001;45(5):1595-1598. [http://dx.doi.org/10.1128/AAC.45.5.1595-1598.2001].
24. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprimsulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J 2001;20(3):260-264. [http://dx.doi.org/10.1097/00006454-200103000-00009].
25. Ingvarsson L, Lundgren K. Penicillin treatment of acute otitis media in children: A study of the duration of treatment. Acta Otolaryngol 1982;94(3-4):283-287. [http://dx.doi.org/10.3109/00016488209128915].
26. Leibovitz E, Dagan R. Otitis media therapy and drug resistance. Infect Med 2001;18(4):263-270.
27. Pichichero NE. Use of selected cephalosporins in penicillin allergic patients: A paradigm shift. Diagn Microbiol Infect Dis 2007;57(Suppl 7):13s-18s. [http://dx.doi.org/10.1016/j.diagmicrobio.2006.12.004].
28. Joint task force on practice parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: An updated practice parameter. Ann Allergy Asthma Immunol 2010;105(4):259-273. [http://dx.doi.org/10.1016/j.anai.2010.08.002].
29. Arguedas A, Dagan R, Pichichero M, et al. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. Pediatr Infect Dis J 2006;25(12):1102-1109. [http://dx.doi.org/10.1097/01.inf.0000202138.12950.3c].
30. Bradley JS, Jackson MA. The use of systemic and topical fluoroquinolones. Pediatrics 2011;128(4):e1034-1045. [http://dx.doi.org/10.1542/peds.2011-1496].
31. Noel GJ, Bradley JS, Kauffman RE, et al. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J 2007;26(10):879-891. [http://dx.doi.org/10.1097/INF.0b013e3180cbd382].